NFKB1 and B-cell chronic lymphocytic leukemia: Members of the miR-9 family (miR-9-3) can be silenced in CLL patients and cell lines by methylation and are implicated in NF-κB activation [98], likely through direct targeting of the 3′ UTR of the p50 subunit of NF-κB [99].